Trade

Panacea Biotec share price

High risk
  • 57%Low risk
  • 57%Moderate risk
  • 57%Balanced risk
  • 57%High risk
  • 57%Extreme risk
  • 387.00(0.58%)
    May 15, 2026 15:12:54 PM IST
    • NSE
    • BSE
  • Vol : 98.17 K (NSE + BSE)
    Last 20 day avg : 175.73 K

Panacea Biotec is trading 0.58% upper at Rs 387.00 as compared to its last closing price. Panacea Biotec has been trading in the price range of 390.80 & 380.45. Panacea Biotec has given 1.98% in this year & -4.95% in the last 5 days. The company posted a net profit of 3.98 Crores in its last quarter.Listed peers of Panacea Biotec include Sun Pharmaceutical Industries (0.90%), Cipla (-0.49%), Torrent Pharmaceuticals (-0.52%).The Mutual Fund holding in Panacea Biotec was at -% in . The MF holding has - from the last quarter. The FII holding in Panacea Biotec was at 1.60% in 31 Mar 2026. The FII holding has increased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on May 15, 2026, 01:10 PM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    1.04
    Medium volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.03
    Higher than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    -
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
380.45
Highest
390.80
52 week range
Lowest
293.10
Highest
581.00
Panacea Biotec Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Sun Pharmaceutical Industries
Bullish
1,879.900.904,51,076.6736.245.770.920.50
Cipla
Moderately Bullish
1,431.55-0.491,16,013.1022.953.870.870.81
Torrent Pharmaceuticals
Bullish
4,386.00-0.521,48,148.9267.3217.10.8317.62
Divi's Laboratories
Bullish
6,755.00-2.411,78,679.9978.6111.520.460.01
Dr Reddy's Laboratories
Bullish
1,336.952.621,11,584.2418.633.140.632.34
Panacea Biotec Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-02-11Quarterly Results
2025-11-14Quarterly Results
2025-08-14Quarterly Results
2025-05-30Audited Results & Dividend
2025-02-14Quarterly Results
About the company Panacea Biotec
  • IndustryBiotechnology & Drugs
  • ISININE922B01023
  • BSE Code531349
  • NSE CodePANACEABIO
Panacea Biotec Limited is an India-based pharmaceutical and biotechnology company with research, manufacturing and marketing capabilities. The Company is engaged in the business of research, development, manufacture and marketing of branded vaccines, pharmaceutical formulations, nutraceuticals and food and nutrition products in India and international markets. Its segments include vaccines and formulations. It has specialized in the development of fully liquid combination vaccines that can be stored at 2-8 degree Celsius temperature. Its vaccine portfolio includes EasySix (DTwP-Hib-HepB-IPV), EasyFive-TITM (DTwP-Hib-HepB), EasyFour-TI (DTwP-Hib), EasyFourPol (DTwP-IPV) and Bivalent oral polio vaccine (type-1 and type-3). Its pipeline vaccines include NucoVac 11, DengiALL and Td (tetanus and diphtheria - reduced). Its pharmaceutical formulation products include Sitcom Tablets and Sitcom Cream. Its nutrition product brand names include ChilRunfull, ChilRun 7+ and ChilRun NoSucrose.
  • Management Info
  • Rajesh JainExecutive Chairman of the Board, Managing Director
  • Vinod GoelGroup Chief Financial Officer, Head Legal & Corporate Governance
  • Ankesh JainCompliance Officer, Executive Director, Company Secretary
  • Sandeep JainJoint Managing Director, Executive Director
  • Harshet JainWhole Time Director
  • Sanjay TrehanDirector - Technical & Compliances
Panacea Biotec Share Price FAQs

Panacea Biotec is trading at 387.00 as on Fri May 15 2026 09:42:54. This is 0.58% upper as compared to its previous closing price of 384.75.

The market capitalization of Panacea Biotec is 2370.40 Cr as on Fri May 15 2026 09:42:54.

The 52 wk high for Panacea Biotec is 581.00 whereas the 52 wk low is 293.10

Panacea Biotec can be analyzed on the following key metrics -

  • TTM P/E:
  • Sector P/E: 40.41
  • Dividend Yield: 0.00%
  • D/E ratio: -

Panacea Biotec reported a net profit of -8.37 Cr in 2025.